Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of conventional and spatially resolved angle resolved photoemission spectroscopy with spin resolution. The post holder provides guidance to less experienced members of the research group, such as PhD and project
-
medically qualified, ST3 and above, have full GMC registration and already hold, or have submitted for Higher Degree (PhD/DPhil/MD). Applicants must also hold a current National Training Number (NTN
-
biotechnology, design, and engineering across Northumbria, Oxford, and Imperial, as well as start-ups and SME collaborators who are already bringing novel materials to market. Applicants should hold a PhD, or be
-
include taking part in assessment and examining and supporting the delivery of the departmental masters programme. The successful applicant will have a relevant PhD or DPhil with post-qualification teaching
-
also runs an enormous amount of social groups and sports clubs for those looking for more than just a great place to work. About you You will hold a PhD/DPhil or be near completion of a PhD/DPhil in
-
. Lead and contribute to teaching, supervision, and research. Oversee student engagement and admissions, and enhance teaching methods. What You'll Bring You will hold a PhD/DPhil or a relevant Master’s
-
to implantation, including validating methods in virtual in vivo environments. • Collaborate with engineers to refine fuel cell specifications and support in vivo experiments. You should hold a relevant PhD
-
, including projects that could support future fellowship or independent position applications. Applicants should hold, or be close to completion of, a PhD/DPhil in biochemistry, molecular biology, structural
-
students. Applicants should hold a PhD, or be close to completion of one, in physics or a related field. A strong experience in the discipline of Theoretical Astroparticle Physics would be essential as
-
We are seeking to appoint a highly motivated Postdoctoral Researcher to join the research group of Professor Ignacio Melero, MD PhD, at the Oxford Centre for Immuno-Oncology within the Nuffield